Unknown

Dataset Information

0

Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France.

ABSTRACT:

SUBMITTER: Letailleur V 

PROVIDER: S-EPMC9856420 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France.

Letailleur Valentin V   Le Bourgeois Amandine A   Guillaume Thierry T   Jullien Maxime M   Coste-Burel Marianne M   Béné Marie C MC   Chevallier Patrice P  

JAMA network open 20221201 12

Similar Datasets

Unknown Serum Neutralization of Omicron XBB.1.5 in Kidney Transplant Recipients After Bivalent mRNA Booster Vaccination.
| S-EPMC10219672 | biostudies-literature
Unknown Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients.
| S-EPMC10909407 | biostudies-literature
Unknown The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.
| S-EPMC11209529 | biostudies-literature
Unknown Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes.
| S-EPMC9990563 | biostudies-literature
Unknown The Omicron wave and the waning of COVID-19 vaccine effectiveness. Influence of vaccine booster and age on confirmed infection incidence.
| S-EPMC9132883 | biostudies-literature
Unknown Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
| S-EPMC9278130 | biostudies-literature
Unknown Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France.
| S-EPMC5324811 | biostudies-literature
Unknown Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
| S-EPMC9506309 | biostudies-literature
Unknown Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
| S-EPMC9052011 | biostudies-literature
Unknown Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
| S-EPMC9906353 | biostudies-literature